Collaboration with patient groups
Partnerships and collaboration with patient organisations are essential to our strategic priority of helping people with diabetes or other chronic conditions live better lives. These interactions provide us with valuable insights into how the lives of people with chronic conditions are affected. In addition, assistance from pharmaceutical companies like us helps patient organisations to carry out their work in support of patients and their caregivers.
We collaborate with patient organisations in an open and transparent manner to ensure their independence and integrity and our own ethical standards. Our support is based on written agreements that clearly state the purpose of the support as well as the amount and a description of indirect support and any significant non-financial support.
Disclosure of support
In accordance with industry guidelines in Europe, Novo Nordisk has made details about how we work with patient groups in Europe publicly available. This includes a list of collaboration projects, a short description of the nature of the support, and any financial support.
Codes of practice on relationships between the pharmaceutical industry and patient organisationsEFPIA* Code of Practice
*European Federation of Pharmaceutical Industries and Associations
National collaboration with patient groups
Lists of national collaborations with patient organisations can be found at the Novo Nordisk affiliates’ websites.
Visit the Global Offices page to locate affiliate or use the quick links below.
Quick links to Novo Nordisk affiliates' websites in European region
Disclosure from Novo Nordisk affiliates in the European region with no website
FYROM - Macedonia
International collaboration with patient groups
For list of collaborations see below:
The International Diabetes Federation (IDF)
The International Diabetes Federation (IDF) Region Europe
International Diabetes Federation (IDF) Region Africa
World Federation of Hemophilia
International Asssociation of Patients' Organizations
Additional patient group fundings
If unable to locate specific projects, please consult the relevant Novo Nordisk national affiliate's website.